18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosis ; day:20 ; month:5 ; year:2020 ; pages:1-2
European journal of nuclear medicine and molecular imaging ; (20.5.2020), 1-2
- Creator
-
Papathanasiou, Maria
Carpinteiro, Alexander
Hagenacker, Tim
Herrmann, Ken
Rassaf, Tienush
Rischpler, Christoph
Luedike, Peter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-020-04861-4
- URN
-
urn:nbn:de:101:1-2020081123173474360106
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Papathanasiou, Maria
- Carpinteiro, Alexander
- Hagenacker, Tim
- Herrmann, Ken
- Rassaf, Tienush
- Rischpler, Christoph
- Luedike, Peter
- SpringerLink (Online service)
Other Objects (12)
18F-flutemetamol positron emission tomography in cardiac amyloidosis
Assoziation zwischen molekularpathologischen Alterationen beim papillären Schilddrüsenkarzinom und dem Auftreten einer radiojodrefraktären Erkrankung
Affordable and personalized solutions for radiation therapy of superficial skin tumors : [kumulative Dissertation]
Hybrid total-body pet scanners—current status and future perspectives
Hybrid total-body pet scanners—current status and future perspectives
CXCR4 ligands: the next big hit?
The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?
2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer
Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
18F-flutemetamol positron emission tomography in cardiac amyloidosis
Assoziation zwischen molekularpathologischen Alterationen beim papillären Schilddrüsenkarzinom und dem Auftreten einer radiojodrefraktären Erkrankung
Affordable and personalized solutions for radiation therapy of superficial skin tumors : [kumulative Dissertation]
Hybrid total-body pet scanners—current status and future perspectives
Hybrid total-body pet scanners—current status and future perspectives
CXCR4 ligands: the next big hit?
The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?
2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer
Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
18F-flutemetamol positron emission tomography in cardiac amyloidosis
Assoziation zwischen molekularpathologischen Alterationen beim papillären Schilddrüsenkarzinom und dem Auftreten einer radiojodrefraktären Erkrankung
Affordable and personalized solutions for radiation therapy of superficial skin tumors : [kumulative Dissertation]
Hybrid total-body pet scanners—current status and future perspectives
Hybrid total-body pet scanners—current status and future perspectives
CXCR4 ligands: the next big hit?
The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?
2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer